Narges Nasrollahi

Studenti Visitatori e Alumni

narges.nasrollahi@gmail.com

Biografia

Narges Nasrollahi è ricercatrice in Neuroscienze Molecolari, specializzata nella somministrazione mirata mediata da FUS e nelle nanobolle attraverso la BBB. È titolare di un brevetto per la sintesi di nanobolle contenenti farmaci biogenerici per la somministrazione mirata con FUS, registrato come PCT.

La sua ricerca innovativa ha ottenuto un significativo sostegno finanziario, tra cui una borsa di studio sabbatica a Roma da parte dell’Organizzazione iraniana MSRT, oltre a molteplici sovvenzioni da parte dell’Iran Nanotechnology Innovation Council (INIC), della Vicepresidenza iraniana per la scienza e la tecnologia (ISTI), dell’Iran National Science Foundation (INSF), dell’Iran National Innovation Fund (INIF) e del National Institute of Genetic Engineering and Biotechnology (NIGEB).

Gli eccezionali contributi di Narges l’hanno portata a ricevere il primo premio all’evento Phoenix organizzato dalla National Elites Foundation. Il suo progetto si è distinto tra 500 proposte concorrenti, facendole guadagnare un premio di 20.000 dollari. Inoltre, nel 2024 è stata premiata come studente modello al NIGEB.

Profili

Created with Fabric.js 4.6.0

Scopus

Pubmed

LinkedIn

Ultime 5 pubblicazioni (Scopus)

opensearch:totalResults = 3
opensearch:startIndex = 0
opensearch:itemsPerPage = 3
@role = request
@searchTerms = AU-ID(57226827565) OR AU-ID(58976441100)
@startPage = 0

@_fa = true
@ref = self
@href = https://api.elsevier.com/content/search/scopus?start=0&count=25&query=AU-ID%2857226827565%29+OR+AU-ID%2858976441100%29&apiKey=6ae70c855c11cca26b94ca23c22dcbcf
@type = application/json

@_fa = true
@ref = first
@href = https://api.elsevier.com/content/search/scopus?start=0&count=25&query=AU-ID%2857226827565%29+OR+AU-ID%2858976441100%29&apiKey=6ae70c855c11cca26b94ca23c22dcbcf
@type = application/json


inizio

@_fa = true

@_fa = true
@ref = self
@href = https://api.elsevier.com/content/abstract/scopus_id/85189797956

@_fa = true
@ref = author-affiliation
@href = https://api.elsevier.com/content/abstract/scopus_id/85189797956?field=author,affiliation

@_fa = true
@ref = scopus
@href = https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85189797956&origin=inward

@_fa = true
@ref = scopus-citedby
@href = https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85189797956&origin=inward

The impact of hUC MSC–derived exosome-nanoliposome hybrids on α-synuclein fibrillation and neurotoxicity; Science Advances; April 2024; DOI: 10.1126/sciadv.adl3406
prism:url = https://api.elsevier.com/content/abstract/scopus_id/85189797956
dc:identifier = SCOPUS_ID:85189797956
eid = 2-s2.0-85189797956
dc:creator = Aliakbari F.
prism:publicationName = Science Advances
prism:issn =
prism:eIssn = 23752548
prism:volume = 10
prism:issueIdentifier = 14
prism:pageRange =
prism:coverDate = 2024-04-05
prism:coverDisplayDate = April 2024
prism:doi = 10.1126/sciadv.adl3406
citedby-count = 5

@_fa = true
affilname = Robarts Research Institute
affiliation-city = London
affiliation-country = Canada

@_fa = true
affilname = National Institute for Genetic Engineering and Biotechnology Iran
affiliation-city = Tehran
affiliation-country = Iran

pubmed-id = 38569030
prism:aggregationType = Journal
subtype = ar
subtypeDescription = Article
article-number = eadl3406
source-id = 21100457028
openaccess = 1
openaccessFlag = true
value:

$ = all

$ = publisherfullgold

$ = repository

$ = repositoryvor

value:

$ = All Open Access

$ = Gold

$ = Green

prism:isbn:

@_fa =
$ =

pii =

inizio

@_fa = true

@_fa = true
@ref = self
@href = https://api.elsevier.com/content/abstract/scopus_id/85143232428

@_fa = true
@ref = author-affiliation
@href = https://api.elsevier.com/content/abstract/scopus_id/85143232428?field=author,affiliation

@_fa = true
@ref = scopus
@href = https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85143232428&origin=inward

@_fa = true
@ref = scopus-citedby
@href = https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85143232428&origin=inward

Viral and non-viral gene therapy using 3D (bio)printing; Journal of Gene Medicine; December 2022; DOI: 10.1002/jgm.3458
prism:url = https://api.elsevier.com/content/abstract/scopus_id/85143232428
dc:identifier = SCOPUS_ID:85143232428
eid = 2-s2.0-85143232428
dc:creator = Jahangiri S.
prism:publicationName = Journal of Gene Medicine
prism:issn = 1099498X
prism:eIssn = 15212254
prism:volume = 24
prism:issueIdentifier = 12
prism:pageRange =
prism:coverDate = 2022-12-01
prism:coverDisplayDate = December 2022
prism:doi = 10.1002/jgm.3458
citedby-count = 9

@_fa = true
affilname = Université de Montréal, Faculté de Médecine
affiliation-city = Montreal
affiliation-country = Canada

@_fa = true
affilname = Centre Hospitalier de L'Université de Montréal
affiliation-city = Montreal
affiliation-country = Canada

pubmed-id = 36279107
prism:aggregationType = Journal
subtype = re
subtypeDescription = Review
article-number = e3458
source-id = 18922
openaccess = 0
openaccessFlag = false
value:

$ =

value:

$ =

prism:isbn:

@_fa =
$ =

pii =

inizio

@_fa = true

@_fa = true
@ref = self
@href = https://api.elsevier.com/content/abstract/scopus_id/85112803548

@_fa = true
@ref = author-affiliation
@href = https://api.elsevier.com/content/abstract/scopus_id/85112803548?field=author,affiliation

@_fa = true
@ref = scopus
@href = https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85112803548&origin=inward

@_fa = true
@ref = scopus-citedby
@href = https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85112803548&origin=inward

Prevascularized Micro-/Nano-Sized Spheroid/Bead Aggregates for Vascular Tissue Engineering; Nano-Micro Letters; December 2021; DOI: 10.1007/s40820-021-00697-1
prism:url = https://api.elsevier.com/content/abstract/scopus_id/85112803548
dc:identifier = SCOPUS_ID:85112803548
eid = 2-s2.0-85112803548
dc:creator = Rahimnejad M.
prism:publicationName = Nano-Micro Letters
prism:issn = 23116706
prism:eIssn = 21505551
prism:volume = 13
prism:issueIdentifier = 1
prism:pageRange =
prism:coverDate = 2021-12-01
prism:coverDisplayDate = December 2021
prism:doi = 10.1007/s40820-021-00697-1
citedby-count = 47

@_fa = true
affilname = Centre Hospitalier de L'Université de Montréal
affiliation-city = Montreal
affiliation-country = Canada

@_fa = true
affilname = University of Montreal
affiliation-city = Montreal
affiliation-country = Canada

pubmed-id =
prism:aggregationType = Journal
subtype = ar
subtypeDescription = Article
article-number = 182
source-id = 21100203115
openaccess = 1
openaccessFlag = true
value:

$ = all

$ = publisherfullgold

$ = repository

$ = repositoryvor

value:

$ = All Open Access

$ = Gold

$ = Green

prism:isbn:

@_fa =
$ =

pii =

Ultime 5 pubblicazioni PubMed